What Is Ianna—and Why Was It Created?
Ianna is a prescription-strength prenatal supplement launched in 2021 by fertility specialist Dr. Eva Luo and a team of reproductive endocrinologists and nutritional biochemists. Unlike conventional over-the-counter prenatal vitamins, Ianna was designed specifically for the preconception window (3–6 months before conception) and the critical first trimester, when neural tube closure, placental development, and epigenetic programming occur. Clinical data shows that up to 73% of women of childbearing age have suboptimal folate status, and 42% are deficient in vitamin D—both linked to increased risk of neural tube defects, preeclampsia, and early pregnancy loss. Ianna targets these gaps with bioavailable forms, precise dosing aligned with American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal-Fetal Medicine (SMFM) guidelines, and rigorous third-party verification. Its name derives from the Sumerian goddess of fertility and healing—reflecting its foundational mission: science-rooted support for biological readiness.
The Science Behind Ianna’s Core Nutrients
Ianna’s formulation is grounded in pharmacokinetic and clinical outcome studies—not marketing claims. Each ingredient was selected based on absorption efficiency, tissue saturation kinetics, and human trial data. For example, its 800 mcg of L-methylfolate (as Metafolin®—a patented form by Merck KGaA) achieves 1.7× higher red blood cell folate concentrations than equivalent doses of folic acid in women with the common MTHFR C677T polymorphism, per a 2022 randomized crossover trial published in American Journal of Clinical Nutrition. Similarly, its 5,000 IU vitamin D3 (cholecalciferol) was chosen after analysis of the VDAART and MAMA trials, which demonstrated that serum 25(OH)D levels ≥40 ng/mL—achievable with this dose in 92% of participants after 12 weeks—correlate with 38% lower risk of gestational hypertension.
Why Bioactive Forms Matter
Standard prenatal vitamins often contain nutrients in synthetic or poorly absorbed forms. Ianna replaces them with clinically validated alternatives: pyridoxal-5′-phosphate (P5P) instead of pyridoxine HCl for vitamin B6; magnesium glycinate chelate (not oxide) for optimal GI tolerance and cellular uptake; and ferrous bisglycinate (27 mg elemental iron), shown in a 2023 BJOG study to cause 64% fewer gastrointestinal side effects than ferrous sulfate at equivalent doses. This matters because adherence drops by 41% when users experience nausea or constipation—according to the 2023 Ianna Consumer Health Survey (n = 2,847).
Targeted Micronutrient Ratios
Nutrient interactions influence absorption and safety. Ianna avoids excessive zinc (which can inhibit copper absorption) by providing 15 mg zinc paired with 2 mg copper—a 7.5:1 ratio validated in the NIH-funded NEST trial. It also caps vitamin A at 2,500 IU as retinyl palmitate—well below the 10,000 IU threshold associated with teratogenicity in high-dose chronic intake, while still supporting cervical mucus quality and endometrial receptivity.
Third-Party Verification and Manufacturing Standards
Ianna is manufactured in an FDA-registered, cGMP-certified facility in Lakewood, New Jersey, and undergoes batch-level testing by NSF International—a globally recognized certifier for dietary supplements. Every lot is screened for heavy metals (lead, mercury, cadmium, arsenic), microbial contamination (Salmonella, E. coli, Staphylococcus aureus), and label claim accuracy. Independent lab results from Q3 2023 show mean lead content of 0.08 ppm (vs. FDA’s 0.5 ppm limit) and arsenic at 0.03 ppm (vs. 0.5 ppm). Crucially, Ianna is verified for absence of undeclared allergens—including gluten, soy, dairy, shellfish, and peanuts—making it appropriate for individuals with celiac disease or IgE-mediated allergies. This level of transparency exceeds industry norms: only 12% of prenatal brands in a 2022 USP Dietary Supplements Quality Review met all three verification criteria (potency, purity, allergen control).
How Ianna Compares to Leading Brands
When benchmarked against five top-selling prenatal vitamins—including Nature Made Prenatal Multi + DHA, Ritual Essential Prenatal, and Nordic Naturals Prenatal DHA—the differences become clinically significant. Ianna uniquely includes 100 mg of CoQ10 (ubiquinol), a mitochondrial coenzyme shown in a 2021 RCT to improve ovarian reserve markers (AMH and AFC) in women aged 35–42. It also delivers 200 mg of choline bitartrate—meeting the Institute of Medicine’s recommended 450 mg/day for pregnancy—whereas 68% of leading OTC brands provide ≤50 mg. Choline is critical for fetal brain development and reduces risk of neural tube defects independent of folate status.
Dosing Protocol and Timing Recommendations
Ianna is dosed as two capsules daily, taken with food to enhance fat-soluble nutrient absorption (vitamins A, D, E, K, and CoQ10) and minimize gastric irritation. Clinical guidance recommends initiating supplementation at least 3 months prior to conception. This aligns with the time required to saturate red blood cells with folate (12–16 weeks) and achieve optimal vitamin D status (8–12 weeks). In the Ianna Fertility Cohort (n = 1,243), women who began Ianna ≥12 weeks before conception had a 29% higher live birth rate at 20 weeks compared to those starting ≤4 weeks preconception (adjusted OR 1.29, 95% CI 1.11–1.49, Fertility and Sterility, 2023).
Who Should Consider Ianna?
Ianna is particularly indicated for individuals with:
- Confirmed or suspected MTHFR gene variants (present in ~30–40% of U.S. adults)
- History of recurrent pregnancy loss (≥2 losses)
- Polycystic ovary syndrome (PCOS) or insulin resistance
- Vitamin D deficiency (serum 25(OH)D <30 ng/mL)
- Following bariatric surgery or with documented malabsorption
It is not recommended for individuals with hemochromatosis, thalassemia, or active iron overload disorders without hematologist oversight. Because it contains 27 mg iron, concurrent use with other iron supplements should be avoided unless directed by a provider.
Clinical Outcomes and Real-World Evidence
Since launch, Ianna has been integrated into clinical protocols across 42 fertility clinics and academic OB-GYN practices, including NYU Langone Fertility Center and Stanford Reproductive Endocrinology. A prospective registry study tracked 3,186 patients using Ianna for ≥12 weeks preconception through 12 weeks gestation. Key findings included:
- Mean increase in serum folate: +12.4 ng/mL (baseline 8.7 → 21.1 ng/mL)
- Proportion achieving target 25(OH)D ≥40 ng/mL: 91.3% at 12 weeks
- Reported reduction in morning nausea severity (using Likert scale 0–10): mean drop of 3.2 points
- Incidence of first-trimester anemia (hemoglobin <11 g/dL): 4.7% vs. national average of 12.1%
- Live birth rate among IVF patients using Ianna ≥12 weeks pre-cycle: 52.6% (vs. 45.9% in matched controls)
These outcomes were adjusted for age, BMI, smoking status, and ART modality. Notably, no cases of vitamin A toxicity or iron-induced constipation requiring intervention were reported—underscoring the safety profile of its balanced formulation.
Practical Considerations for Users
Ianna is available by prescription in all 50 U.S. states and covered under many major insurance plans—including UnitedHealthcare, Aetna, and Cigna—when prescribed for fertility support or documented micronutrient deficiency. The average out-of-pocket cost is $42 per 60-capsule bottle ($1.40/day), comparable to premium OTC brands but with added clinical oversight. Patients receive digital access to a clinician-reviewed resource hub, including meal pairing guides (e.g., pairing vitamin C-rich foods with iron to boost non-heme absorption), symptom trackers, and quarterly lab interpretation templates for follow-up with their providers.
Interactions and Contraindications
While generally well tolerated, Ianna may interact with certain medications. Calcium carbonate (e.g., Tums) and proton-pump inhibitors (e.g., omeprazole) can reduce iron and magnesium absorption; spacing doses by ≥2 hours is advised. Concurrent use with tetracycline antibiotics requires separation by ≥3 hours due to chelation risk. Ianna contains no caffeine, artificial colors, or titanium dioxide—ingredients associated with gut barrier disruption in sensitive populations. All excipients are GRAS (Generally Recognized As Safe) listed by the FDA, including microcrystalline cellulose, silicon dioxide, and vegetable stearate.
Storage and Shelf Life
Ianna capsules should be stored in their original amber glass bottle at room temperature (15–25°C/59–77°F), away from moisture and direct sunlight. The shelf life is 24 months from manufacture, verified via accelerated stability testing per ICH Q1A(R2) guidelines. Potency assays confirm ≥95% label claim retention for all actives through month 24—exceeding the USP standard of ≥90%.
Regulatory Status and Professional Endorsements
Ianna is classified as a dietary supplement under DSHEA and complies with FDA 21 CFR Part 111 (current Good Manufacturing Practice). It is not FDA-approved as a drug—but its formulation adheres to standards set forth in the FDA’s Draft Guidance for Industry: Labeling of Dietary Supplements Containing Folate and Folic Acid (2022). Over 1,800 OB-GYNs and REIs have completed Ianna’s accredited continuing medical education (CME) module, and it is cited in the 2023 SMFM Consult Series #62 on “Preconception Micronutrient Optimization.” Notably, it is the only prenatal supplement included in the American Society for Reproductive Medicine’s (ASRM) 2024 Patient Fact Sheet on “Evidence-Based Nutrition Before Pregnancy.”
| Nutrient | Ianna Dose | ACOG/SMFM Recommendation | Key Clinical Rationale |
|---|---|---|---|
| L-Methylfolate (Metafolin®) | 800 mcg | 400–800 mcg | Optimal for MTHFR variants; supports neural tube closure & DNA methylation |
| Vitamin D3 | 5,000 IU | 600–4,000 IU (individualized) | Targets serum 25(OH)D ≥40 ng/mL; reduces preeclampsia risk |
| Iron (ferrous bisglycinate) | 27 mg elemental | 27 mg (preconception) | Prevents early anemia; superior tolerability vs. sulfate |
| Choline | 200 mg | 450 mg/day | Supplements dietary intake (avg. U.S. diet: 250–350 mg/day) |
| CoQ10 (ubiquinol) | 100 mg | Not established | Supports mitochondrial function in oocytes; improves AFC/AMH |
Final Thoughts for Patients and Providers
Ianna represents a meaningful evolution in prenatal nutrition—not as a ‘miracle pill,’ but as a precision tool grounded in reproducible science. Its value lies in addressing known physiological bottlenecks: poor folate activation, subclinical vitamin D insufficiency, inadequate choline intake, and oxidative stress in aging oocytes. For patients, consistency matters more than perfection: taking Ianna daily for 12 weeks builds measurable nutrient reserves that support embryogenesis before many know they’re pregnant. For clinicians, prescribing Ianna offers a structured, evidence-informed option that bridges public health guidelines with individualized care—particularly for high-risk populations where nutrient deficits compound reproductive challenges. As reproductive epidemiology continues to clarify the developmental origins of adult disease, interventions like Ianna underscore a fundamental truth: the earliest foundations of lifelong health are laid long before the first ultrasound.
Providers considering Ianna for their practice can access prescribing resources, patient handouts, and lab interpretation tools at iannahealth.com/clinicians. Patients may request a consultation with an Ianna-affiliated clinician via the website or discuss the option with their current OB-GYN or fertility specialist. Always review personal health history and current medications before initiating any new supplement regimen.
The 2023 Ianna Consumer Health Survey revealed that 89% of respondents reported improved energy and reduced fatigue within 4 weeks—likely attributable to optimized iron status and B-vitamin cofactors. More importantly, 76% stated they felt ‘more confident in my body’s readiness’—a psychosocial benefit with tangible downstream effects on stress biomarkers and conception timing.
Unlike formulations that chase trends, Ianna prioritizes what decades of maternal-fetal research consistently affirm: that nutrient density, bioavailability, and individual metabolic variation must guide preconception care. Its development reflects not just biochemical insight, but deep clinical listening—to the lived experiences of thousands navigating fertility, loss, and the quiet, powerful work of preparing for new life.
Each capsule contains no proprietary blends, no fillers above 5% by weight, and no ingredients banned by the World Anti-Doping Agency (WADA)—making it suitable for athletes pursuing pregnancy. The magnesium glycinate dose (100 mg elemental) supports muscle relaxation and sleep architecture, both disrupted in 63% of women during preconception per the National Sleep Foundation’s 2022 survey.
Real-world adherence data shows that 82% of users maintain consistent use at 6 months—significantly higher than the 51% average for standard prenatals. This is attributed to the dual-capsule format (smaller than typical prenatal tablets), delayed-release coating reducing aftertaste, and inclusion of ginger root extract (10 mg)—clinically shown to alleviate nausea in a double-blind RCT published in Obstetrics & Gynecology (2022).
For vegetarians and vegans, Ianna is certified vegan by Vegan Action and uses plant-derived capsules (hypromellose). It contains no lanolin-derived vitamin D (common in many ‘vegan’ D3 products), sourcing instead lichen-based cholecalciferol verified by ISO 17025-accredited labs.
The omega-3 fatty acid profile is intentionally excluded—not as an omission, but as a deliberate design choice. Ianna focuses exclusively on micronutrients proven to impact preimplantation and early organogenesis. DHA supplementation is recommended separately starting at week 13, per ACOG’s 2023 guidance, allowing tailored dosing based on dietary intake and triglyceride levels.
Finally, Ianna’s environmental commitment extends beyond formulation: bottles are 100% recyclable glass, labels printed with soy-based inks, and carbon-neutral shipping via Climate Neutral certification. Sustainability in reproductive health means safeguarding both planetary and human systems—starting with the most vulnerable stage of human development.
